Mirabegron/solifenacin - Astellas Pharma
Alternative Names: EB 178; Solifenacin/mirabegron; YM178/YM905; YM905/YM178Latest Information Update: 19 Sep 2024
At a glance
- Originator Astellas Pharma Europe Ltd
- Class Acetamides; Esters; Ethanolamines; Isoquinolines; Quinuclidines; Small molecules; Thiazoles; Urologics
- Mechanism of Action Beta 3 adrenergic receptor agonists; Muscarinic M3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Overactive bladder